Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: horsegirl48 who wrote (8804)	1/11/2001 12:58:51 PM
From: rx4pain	Respond to of 13572

HG48-The drug you are talking about is Fosamax, by Merck. Yes it originally came out in a once daily pill, with all those requirements you listed. However, very recently, they have released the same medication, in a higher strength that can be taken once a week. You only have to put up with that stuff just 1 morning every 7 days. I would not put a single cent into a company whose fortune hinges on a drug that has to be given IV, once a month, for the rest of one's life. Its tough enough to get some people to take just 1 pill per day with no lifestyle infringements. Very, very low patient compliance I would reasonably imagine. Something like that would have necessarily a very limited market. Be careful,don't get caught up in that hype. Rx I have no positions in any drug companies, outside of a few shares in my wife's 401k(not Merck).